Cover Image: June 2010 Scientific American Magazine See Inside

Predictive Modeling Warns Drivers One Hour before Jams Occur

Traffic avoided: Software uses road sensors, GPS and historical traffic data to predict congestion















Share on Tumblr

traffic

BACKUP PLAN: A new service from IBM would predict congestion up to 60 minutes ahead of time and suggest alternative routes. Image: CHARLES GULLUNG/GETTY IMAGES

Onboard navigation and mobile applications can tell drivers how to avoid traffic jams. Trouble is, most of the drivers are already on the road, perhaps already in the jam. But IBM is about to deploy a system that will predict traffic flow up to an hour before it occurs, giving travelers ample time to avoid trouble.

During pilot tests in Singapore, forecasts made across 500 urban locations accurately predicted traffic volume 85 to 93 percent of the time and vehicle speed 87 to 95 percent of the time. Similar results were achieved in Finland and on the New Jersey Turnpike.

The key to success is predictive modeling—software that combines real-time data from road sensors and cameras, as well as GPS transponders in taxis, with historical traffic information, roadwork conditions and weather forecasts. Each week the model recalibrates based on statistics from the most recent six weeks. It broadcasts advisories to electronic road signs and car navigation displays. The system also predicts when a congested road will return to normal flow.

IBM has signed contracts with two U.S. transportation authorities to deploy a full system, according to spokesperson Jenny Hunter. The locations will be announced soon. Singapore may commit as well and is also testing a variation that will predict bus arrival times for riders waiting at bus stops.

In each location, ongoing work will optimize the advisories. If, for example, Highway 1 is clogged and too many drivers who receive messages flock to Highway 2, it will become clogged; engineers will customize the model so it can determine whether sending the messages to only 25 or 40 percent of drivers, say, would best balance the two roads. And because a high percentage of drivers now carry cell phones, IBM is working with several telecom companies to be able to track the continually changing density of their phones along roadways, which could provide finer-grained modeling. To protect privacy, the identity of individual phones would not be disclosed.

The company has also announced its intention to develop services that could tell individual subscribers ahead of time which of various routes would get them to their preselected destination fastest, given current conditions. Voice recommendations would be sent to a person’s vehicle navigator or cell phone.

Similar analytics are being applied to other applications. “The beauty of predictive modeling is that it translates across disciplines,” says Robert Morris, IBM’s vice president of service research in Armonk, N.Y. For example, the company’s laboratory in Haifa, Israel, is testing a program called EuResist that predicts the success of different drug cocktails for an HIV patient over time. The software analyzes the person’s HIV genotype and his or her current health characteristics against an evolving database of treatment outcomes for more than 33,000 patients and 98,000 therapies. Similar applications might determine which type of breast or prostate cancer treatment could benefit a patient most.

IBM is also working with the Washington, D.C., Water and Sewer Authority to predict in real time where problems are likely to arise—such as which sewer lines might flood during storms. The goal is to adjust valves ahead of time, systemwide, to minimize overflows and to deploy maintenance crews to specific locations early. In March, IBM opened a predictive analytics lab in Xi’an, China, to help business clients such as Xi’an City Commercial Bank anticipate customer trends before they occur.



Subscribe     Buy This Issue

Already a Digital subscriber? Sign-in Now
If your institution has site license access, enter here.
Rights & Permissions

3 Comments

Add Comment
View
  1. 1. jtdwyer 01:16 PM 5/19/10

    You know, most of us local drivers can already predict where most of the jams will occur, weeks in advance...

    Reply | Report Abuse | Link to this
  2. 2. marcusjk 08:42 AM 5/24/10

    This system has already been developed and is operating in Maidstone, County Kent ,UK. It was developed for them by their consultant. Traffic congestion predictions into the future, an hour, a day, a week, or a month in advance. All traffic modes, all the time. The use of cellphones as a data source. This is useful for both public agencies and for the public. It has been operating for 2 yrs.

    Reply | Report Abuse | Link to this
  3. 3. Judge Schonfeld 11:34 AM 7/1/10

    At CureHunter Inc. we build original network graph predictive models for new drug discovery based on several types of traffic analysis: the pattern and flow rates of biological agents, drug-induced chemical signaling, and clinical outcome knowledge vectors aggregated by disease hubs. Often biomedical "knowledge jams" help us find new pathways for curing diseases (another way to get there); and we now have standard computational methods and data sets for optimizing the treatment of complex diseases like cancer and autoimmune illnesses of many kinds. As the CEO of CureHunter, obviously I have a vested interest in these types of models; but I believe along with IBM and other scientists around the world that we can get major predictive insights into human systems biology by borrowing high precision methods from other technical fields: Computational Fluid Dynamics, Finite Element Modeling, TCP or, as we say at CureHunter "Transmissive Curative Packet" networking. It is both a metaphor and a functional description of chemical signaling to say that drugs talk to diseases. By measuring that chatter and monitoring which cells respond to drug "tweets" like "turn off your hormones," "uptake your calcium," and "die evil tumor die," for example, we can use communications flow traffic analysis to find what works. What works to make us well. In 2007, Dr. Marc Vidal of the Dana-Farber Cancer Research Institute, Dr. Laszlo Barabasi (author of Linked) and other scientists published "The Human Disease Network," in the Proceedings of the National Academy of Sciences showing how gene network analysis can be used to predict which genetic clusters (a type of genomic traffic) will cause diseases. Using a similar approach, we predict which drugs will cure diseases and have developed extensive re-targeting data libraries derived from the traffic flow of successful clinical messaging. By looking at network graphs as types of metabolic road maps, we can ask the CureHunter computer to find us the shortest path to good health whether major med freeway or "off-road," off-label little known routing solution when our doctor has run out of all known pathways for getting us home to homeostasis.

    Judge Schonfeld

    Reply | Report Abuse | Link to this
Leave this field empty

Add a Comment

You must sign in or register as a ScientificAmerican.com member to submit a comment.
Click one of the buttons below to register using an existing Social Account.

More from Scientific American

See what we're tweeting about

Scientific American Editors

Tweets could not be retrieved at this time

Free Newsletters


Get the best from Scientific American in your inbox

Solve Innovation Challenges

Powered By: Innocentive

  SA Digital
  SA Digital

Science Jobs of the Week

Email this Article

Predictive Modeling Warns Drivers One Hour before Jams Occur: Scientific American Magazine

X
Scientific American MIND iPad

Tap into your MIND

Get Both Print & Tablet Editions for one low price!

Subscribe Now >>

X

Please Log In

Forgot: Password

X

Account Linking

Welcome, . Do you have an existing ScientificAmerican.com account?

Yes, please link my existing account with for quick, secure access.



Forgot Password?

No, I would like to create a new account with my profile information.

Create Account
X

Report Abuse

Are you sure?

X

Institutional Access

It has been identified that the institution you are trying to access this article from has institutional site license access to Scientific American on nature.com. To access this article in its entirety through site license access, click below.

Site license access
X

Error

X

Share this Article

X